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NomeNclature
AChE     Acetylcholinesterase
DFP        Diisopropyl phosphorofluoridate
GC         Gas chromatography
IR           Infrared spectroscopy
NMR      Nuclear magnetic resonance spectroscopy
TLC       Thin layer chromatography
1.  INtroductIoN
Organophosphorus (OP) pesticides such as O,O-
diethyl-O-(4-nitrophenyl) phosphate (paraxon), diisopropyl 
chlorophosphate (DFP) have  been used as pesticides 
extensively causing approximately three million pesticide 
related poisoning (both intentional and occupational) world 
wide resulting in the death of three hundred thousands of human 
lives annually1,2. Further, a large volume of organophosphorus 
(OP) based chemical warfare (CW) agents viz. tabun, soman, 
sarin and VX are still available (Fig.1). In spite of the continued 
efforts by the world community to prevent production, storage 
and use of these deadly CW agents, they have frequently been 
used during war3,4 and terrorism5,6 displays that they constitute 
a major threat for the civilisation.
The acute toxicity of OP compounds is attributed to 
their irreversible inhibition of cholinesterase (ChE) family of 
enzymes including acetylcholinesterase (AChE)7, a critically 
important central nervous system (CNS) and peripheral nervous 
system (PNS) enzyme that hydrolyses the neurotransmitter 
acetylcholine (ACh), into choline and acetate anion8,9. The 
resultant increase in the level of ACh at cholinergic synapses 
produces an acute cholinergic crisis characterised by miosis, 
increased tracheobronchial and salivary secretions, bradycardia 
and convulsions resulting in death by respiratory failures10.
Currently pyridostigmine bromide, a spontaneously 
reactivating inhibitor of enzyme AChE to prevent irreversible 
inhibition of AChE by OP compounds has been used as a 
pretreatment measure of OP poisoning.  However, therapeutic 
treatment of OP poisoning consists of a combination of 
anticholiergic drugs such as atropine and a reactivator such as 
oxime (Fig. 2) to reactivate OP inhibited AChE11,12. Currently, 
pyridiniumaldoximes are the only clinically used reactivators 
available organophosphorus poisoning. OP inhibited enzyme 
is generally reactivated by the attack of a strong nucleophile 
(oximino anion) at the electron defficient P-atom of the OP-
AChE complex. Oximes such as 2-(Hydroxyiminomethyl)-1-
methylpyridinium chloride (2-PAM) and several other oximes 
are developed in the past as reactivators for OP poisoning13,14. 
One of the most widely used reactivator is 2-PAM, developed 
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Figure 1. organophosphorus pesticides and nerve agents.
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in the late 1950s by Ginsberg and Wilson15. While 2-PAM is 
effective against sarin, diisopropylphosphoro-fluoridate (DFP) 
and ethyldimethyl phosphoramidocyanidate (tabun); its efficacy 
against 3, 3’-dimethyl-2-butyl methyl phosphonofluoridate 
(soman) is marginal11. Further, 1-[(4-carbamoylpyridino)-
methoxy methyl]-2-[(hydroxyimino)methyl] pyridinium 
dichloride (HI-6) though effective against soman, is unstable. 
Therefore, research in this area is focused on to find a least 
toxic and stable oxime which would be effective against all 
the nerve agents11,16-17. Mono- and bis-pyridinium oximes have 
been used as AChE reactivators in OP intoxication18,19. The 
standard oximes available today as antidotes are obidoxime 
(toxogonin), HI-6 and TMB-4. The oxime HI-6 has been 
reported as an effective reactivator of non-aged soman 
inhibited human AChE18-21. Further an effective therapy by a 
single oxime for a broad spectrum of OP pesticides and nerve 
agents is still lacking.
Recently several bis-pyridinim-aldoximes connected by a 
variable length alkylene and bis-methoxy alkane chain were 
reported as AChE reactivators21-23. Some of these oximes have 
shown enhanced reactivation potential against OP inhibited 
AChE and led us to further explore the synthesis of bis-
pyridinium oximes using a variety of linkers. In continuation of 
our work on the reactivators for OP-inhibited AChE25, here in 
the evaluation of a series of bis-pyridinium oximes connected 
by xylene bridge as reactivators of DFP-inhibited AChE is 
reported. 
Hence, in the present work we have carried out a systematic 
study on the synthesis and in-vitro reactivation efficacy of bis-
pyridinium oximes connected by xylene linker between two 
pyridinium rings against DFP inhibited electric eel AChE.
2.  materIals aNd methods
2.1 chemicals
Electric eel AChE (EC.3.1.1.7), 5, 5’-dithiobis-(2-
nitrobenzoic acid) (DTNB), acetylthiocholineiodide, and 2-, 
3- & 4-pyridinealdoxime, α,αꞌ-dibromoxylene were purchased 
from Sigma-Aldrich, USA and used without further purification. 
Potassium dihydrogen-phosphate and dipotassium-hydrogen 
phosphate were purchased from E. Merck (India) and used 
without further purification. Solvents (acetonitrile, acetone, 
methanol) were purchased from s.d. Fine Chemicals (India) 
and dried before use. DFP was prepared in this laboratory with 
> 98 per cent purity (GC and 31P NMR). 2-PAM was prepared 
according to the reported method15. The bis-pyridinium oximes 
and obidoxime were synthesised, characterised by their 1H 
NMR and 13C NMR chemical shift values and their purity was 
checked by TLC (cellulose, DSO, Fluka) with 1-butanol: acetic 
acid: water (3:1:1) as solvent system24.
2.2 synthesis of Bis-pyridinium oximes
The synthesis of bis-pyridinium oximes (3a-3h) were 
reported earlier26.  The reaction involved alkylations of pyridine- 
aldoxime (1) with isomeric α,αꞌ-dibromoxylene (2) (Scheme 1) 
to form the desired oximes (3) (as shown in Table 1) and 
characterised by their IR 1H and 13C NMR chemical shifts26.
2.3 In-vitro reactivation study
The in-vitro reactivation efficacy of the synthesised 
oximes (3a-3h) were evaluated against DFP inhibited AChE 
in phosphate buffer (0.1 M, pH 8.0 at 37 °C) using enzyme 
assay protocol of Ellman27, et al. Values depicted in figures 
are average of three runs with maximum relative standard 
deviation of +2 per cent. AChE stock solution (stock A) was 
prepared in phosphate buffer (pH 7.6, 0.1 M) (352 units/0.5 
mL). An aliquot of stock A was then diluted 50 times with 
phosphate buffer to give stock B.  Stock solution of DFP (1.08 
x 10-2 M) was freshly prepared in isopropanol and stored under 
refrigeration. It was then diluted appropriately with triple 
distilled water just before use. All oxime stock solutions were 
prepared in triple distilled water. DTNB stock (10 mM) and 
acetylthiocholineiodide (75 mM) were prepared in phosphate 
scheme 1. synthesis of bis-pyridinium oximes
Figure 2. oximes used as reactivators of oP inhibited ache.
table1.  structure of bis-pyridinum oximes evaluated against 
dFP-inhibited ache
oxime -ch=Noh Xylene 
3a 4 para-
3b 3 para-
3c 2 para-
3d 4 meta-
3e 3 meta-
3f 4 ortho-
3g 3 ortho-
3h 2 ortho-
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buffer (pH 7.6, 0.1 M) and distilled water, respectively. Fifty 
microlitre of DFP (1.08 x 10-4 M) was added to a mixture of 
50 µL enzyme (stock B) in 350 µL phosphate buffer pH 8.0 
(0.1 M) to prepare the DFP inhibited enzyme. The mixture was 
allowed to stand for 15 min at ambient temperature to give 95-
97 per cent inhibition of enzyme activity. Further increase in 
the inhibition of enzyme activity was not observed even after 
1 h of the inhibition with DFP at this concentration. It was 
then followed by addition of 50 µL of oxime test solution (1 
x 10-2 M, 1 x 10-3 M) to start reactivation. The final volume of 
the reactivation cocktail was 500 µL. The final concentration 
of DFP was 1.08x10-5 M and oxime was diluted 10 fold in 
the reactivation cocktail. After 10 minutes of reactivation the 
enzyme activity was assayed by Ellman’s method (Fig. 3). 
Twnwty microlitre of reactivation cocktail was added to a 
cuvette containing 50 µL DTNB in phosphate buffer (pH 8.0, 
0.1M). The enzyme activity was then assayed by addition of 
50 µL of substrate to the cuvette against a blank containing 
reactivation cocktail without substrate. The final volume of the 
assay mixture was adjusted to 3 mL and final concentration of 
DTNB and substrate was 0.16 mM and 1.25 mM, respectively. 
The reactivation of inhibited enzyme was then studied at an 
interval of 10 minutes and followed up to 1h (as shown in Fig. 
4). Percentage reactivation was calculated using the following 
Eqn24,26. 
 Per cent Reactivation = (Er-Ei /Eo-Ei) x 100
where Eo is the initial enzyme activity at 0 min (without 
inhibitor and oxime), Ei is the activity of inhibited enzyme 
determined in the similar manner described above and Er is 
the activity of reactivated enzyme after incubation with the 
oxime test compounds. Spontaneous reactivation of inhibited 
AChE was assayed using the same protocol, the reaction 
mixture contained enzyme and DFP but no oxime. Under 
these conditions spontaneous reactivation was found to be 
insignificant. Values are corrected for their oxime induced 
hydrolysis. 
3. results 
The reactivation of DFP inhibited AChE by these oximes 
was studied at two different concentrations i.e., 10-3 M and 
10-4 M. However, it was observed that none of these oximes 
surpassed the reactivation efficacy of 2-PAM and obidoxime 
in reactivating DFP inhibited AChE. 2-PAM and obidoxime 
respectively exhibited 52 per cent and 43 per cent reactivation 
of DFP inhibited AChE where as the synthesised oximes 
3a, 3d and 3f showed 37 per cent, 30 per cent and 31 per 
cent, respectively within 10 minutes at 10-3 M (as shown in 
Fig. 3). Earlier it was demonstrated that 3b reactivated the 
sarin-inhibited AChE more effectively in comparison to the 
2-PAM even at a lower concentration.26 It can also be noted 
that all the 4-isomers (oximino moiety in the 4-position of 
pyridinium ring) of bis-pyridinium oximes were found to be 
superior in terms of reactivation potential than their 3- and 
2-isomers for DFP inhibited AChE where as 3-isomers of the 
same were found most potent in reactivating sarin inhibited 
AChE. It further corroborates earlier study (bis-methoxy ethane 
linkages) that reactivation of inhibited enzyme also depends on 
the structure of the inhibitor as well as that of reactivator.17
Further, from the study of the effect of different isomers 
of xylene bridge (as shown in Figs. 3 and 4), it was observed 
that the para-isomers in the xylene linkage showed the 
highest reactivation followed by meta- and ortho-isomers 
(3b > 3e > 3g). 
The time dependent reactivation profile by following 
the reactivation up to 60 min of oxime addition was also 
investigated and has been presented in Fig. 4. However, in case 
of DFP inhibition no time dependent reactivation was observed 
in Fig. 4. The maximum reactivation was observed within 
10 minutes of addition of oxime, after which it began to fall 
sharply. This is in fact, contrast to the earlier study involving 
other class of bis-pyridinium oximes, where reactivation of OP 
inhibited AChE increases with time26,24.
4.  dIscussIoN
The oxime induced reactivation of OP-inhibited AChE 
depend on various factors such as number of pyridinium rings 
(mono or bis-pyridinium), position of the oxime group chemical 
structure and length of theconnecting chain in bis-pyridinium 
oximes22,23 as well as the structure of the OP inhibitor28. Better 
reactivation with the studied bis-pyridinium oximes bearing 
oxime function at 4th position could be attributed to electronic 
and steric effects29. The higher reactivation efficacy of 3a and 
Figure 4. reactivation profile of dFP inhibited ache with 
tested oximes at 1x10-4 m.
Figure 3. Reactivation efficay of the oximes against DFP-inhibited 
ache. source of enzyme: electric eel, inhibitor agent: 
dFP, inhibitor concentration: 1.08x10-5 m, time of 
inhibition: 15 min, time of reactivation: 10 min, ph: 
8.0 and temperature: 37 °c. the values are average 
of three runs with maximum s.d. of ±2 per cent.
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3d for DFP inhibited AChE at the lower concentration 10-4 M 
in comparison to 2-PAM and obidoxime showed that they can 
be promising candidates for in-vivo reactivation as well. The 
higher reactivation potency of the oximes bearing p-xylene 
linkers as compared to their ortho- and meta- analogues may 
be attributed to the fact that the pyridinium rings connected to 
the p-xylene linkers are far away from each other giving rise 
to suitable orientation to be fit in the 20Å active-site gorge of 
the enzyme AChE, where one pyridinium ring might reside at 
the ring of the active site allowing the other ring to penetrate 
through the gorge to bind to the anionic site. The oximino 
moiety on the second ring suitably orients itself to attack on the 
phosphorus atom of the phosphorylated enzyme. Further, the 
xylene group in the linkers might provide suitable non-bonding 
hydrophobic interactions with the aryl residues present in the 
active-site gorge of the enzyme.
In conclusion, we have synthesised series of new bis-
pyridinium oximes and evaluated their in-vitro reactivation 
efficacy against DFP inhibited AChE. Based upon this study, 
3a and 3d may prove a useful therapeutic candidates for the 
reactivation of AChE inhibited by DFP. The detailed study of 
antidotal efficacy including in-vivo reactivation against DFP 
and other nerve agents remains to be explored.
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